The Week Ahead: Fed...
Health Care: Drugs
Alexza Pharmaceuticals Inc. (ALXA: NASDAQ)
$0.36 0.00 | -1.37%
06/01/12 - 04:00 PM ET
Company Balance Sheet
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 14.90M | 13.67M | 13.45M | 26.04M |
| Receivables | 10.00M | 0.00 | 1.41M | 0.00 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 27.55M | 42.41M | 22.13M | 60.00M |
| Property, Plant & Equipment, Gross | 45.08M | 45.05M | 41.01M | 37.18M |
| Accumulated Depreciation & Depletion | 24.65M | 20.69M | 17.41M | 13.03M |
| Property, Plant & Equipment, Net | 20.42M | 24.36M | 23.60M | 24.15M |
| Intangibles | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 628.00K | 1.71M | 450.00K | 479.00K |
| Total Non-Current Assets | 21.05M | 26.07M | 24.05M | 24.63M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 48.60M | 68.48M | 46.17M | 84.64M |
| Accounts Payable | 3.60M | 2.78M | 2.70M | 4.93M |
| Short Term Debt | 12.28M | 0.00 | 2.52M | 4.14M |
| Other Current Liabilities | 12.30M | 23.90M | 16.95M | 0.00 |
| Total Current Liabilities | 34.95M | 34.38M | 25.96M | 17.23M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 2.52M |
| Deferred Income Taxes | 12.27M | 0.00 | 15.71M | 0.00 |
| Other Non-Current Liabilities | 11.08M | 21.81M | 11.64M | 25.83M |
| Minority Interest | 0.00 | 0.00 | -13.99M | -18.59M |
| Total Non-Current Liabilities | 23.35M | 21.81M | 27.34M | 33.71M |
| Total Liabilities | 58.30M | 56.19M | 53.30M | 50.94M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | -9.69M | 12.29M | -7.13M | 33.69M |
| Common Par | 7.00K | 6.00K | 5.00K | 3.00K |
| Additional Paid In Capital | 296.94M | 278.39M | 257.49M | 256.43M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -306.64M | -266.10M | -264.62M | -222.54M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 2.00K | -1.00K | -191.00K |
| Total Capitalization | -9.69M | 12.29M | -7.13M | 36.21M |
| Total Equity | -9.69M | 12.29M | -7.13M | 33.69M |
| Total Liabilities & Stock Equity | 48.60M | 68.48M | 46.17M | 84.64M |
| Total Common Shares Outstanding | 72.14M | 59.77M | 52.41M | 32.82M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 67.87M | 55.42M | 38.61M | 32.30M |
| Diluted Weighted Shares Outstanding | 67.87M | 55.42M | 38.61M | 32.30M |
| Number of Employees | 44 | 97 | 90 | 111 |
| Number of Part-Time Employees | 7 | 0 | 0 | 0 |
Portfolios with ALXA
- Portfolio NameUser Type
- Uservlady 1
- ContributorStocks With Big Insider Buy...
- UserSMITTY
- ContributorBarron's Insider Purchases ...
- UserHi Potential
- UserRAPTOR SPRTD RED-03110081643
- UserScottrade 20K
- UserBburn Portfolio 1
- UserRatBastard Portfolio 1
- Userpornholio
Latest ALXA Headlines from TheStreet
- Friday's Top 10 Articles, Videos on TheStreet 05.04.12 | 01:05 pm
- Alexza Stock Gaps Down On Today's Open (ALXA) 05.04.12 | 09:05 am
- Biotech Stock Mailbag: Exelixis, Protalix, Arena 05.04.12 | 07:05 am
- 26 Drugs Facing FDA Approval in 2012 05.02.12 | 01:05 pm
- The Next Big Thing In Biotech: Alexza
04.13.12 | 06:04 am - Alexza Pharmaceuticals Inc. Stock Downgraded (ALXA) 02.24.12 | 05:02 am
- Alexza Stock Gaps Down On Today's Open (ALXA) 02.17.12 | 08:02 am
- 5 Stocks Insiders Are Loading Up On 01.26.12 | 12:01 pm
- Alexza Stock Gaps Up On Today's Open (ALXA) 01.03.12 | 11:01 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
Press Releases for ALXA
- Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Alexza Pharmaceuticals Inc. - PR Newswire 05.07.12 | 08:05 am
- Alexza And Grupo Ferrer Amend Adasuve⢠Partnership - PR Newswire 03.07.12 | 04:03 pm
- Alexza To Announce 2011 Year-End Financial Results On Monday, March 12, 2012 - PR Newswire 03.05.12 | 09:03 am
- Alexza Prices $22 Million Public Offering - PR Newswire 02.17.12 | 07:02 am
- Alexza Announces Proposed Public Offering Of Common Stock And Warrants - PR Newswire 02.16.12 | 06:02 pm
- Alexza Pharmaceuticals Receives Day 80 Assessment Report For ADASUVE (Staccato® Loxapine) MAA - PR Newswire 02.13.12 | 08:02 am
- Alexza Retains Lazard To Explore Strategic Options - PR Newswire 12.16.11 | 08:12 pm
- FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval Of Alexza's ADASUVE⢠- PR Newswire 12.13.11 | 05:12 am
- Alexza Pharmaceuticals To Present At The Lazard Capital Markets 8th Annual Healthcare Conference - PR Newswire 11.02.11 | 09:11 am
- Alexza To Announce 2011 Third Quarter Financial Results On Monday, November 7, 2011 - PR Newswire 10.27.11 | 06:10 pm
Partner Headlines for ALXA
- Benzinga's Microcap Movers for Friday May 4, 2012 - Benzinga 05.05.12 | 12:05 pm
- 6 Biotech Stocks With Huge Potential In May - Seeking Alpha 04.11.12 | 08:04 am
- Earnings Expectations for the Week of March 12 (URBN, ROST) - Benzinga 03.11.12 | 11:03 am
- Alexza and Grupo Ferrer Amend Adasuve Partnership Alexza and Grupo Ferrer Amend Adasuve Partnership; Ferrer to Purchase 2.42M Shares of Alexza Common Stock for $1.24 per Share - Benzinga 03.07.12 | 04:03 pm
- Analysis Of Institutional 5% Ownership Filings On Tuesday And Wednesday - Seeking Alpha 01.05.12 | 08:01 am
- Microcap Movers for Friday December 9, 2011 - Benzinga 12.09.11 | 06:12 pm
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Company News for October 5, 2011 - Corporate Summary - Zacks 10.05.11 | 10:10 am
- Alexza Pharmaceuticals Nears Daily High; Ready to Breakout - Benzinga 09.07.11 | 01:09 pm
- Alexza Hopes New NDA Submission Will Relieve Agitation - Benzinga 08.17.11 | 01:08 pm
